SCHEMBL13115484

SCHEMBL13115484

O=C(O)Cc1nc(-c2ccc(F)cc2)oc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.61
PTGDR2 Q9Y5Y4 5/20 0.48
USP1 O94782 1/20 0.48
USP19 O94966 1/20 0.48
UCHL3 P15374 1/20 0.48
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.44
PPARG P37231 2/20 0.43
PPARA Q07869 2/20 0.43
ADCY1 Q08828 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ADCY8 P40145 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
HSP90AA1 P07900 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115729 0.96 KDM4E (0.54) KDM4EPTGDR2USP1USP19UCHL3
SCHEMBL10908192 0.91 KDM4E (0.71) KDM4EUSP1USP19NR4A1NR4A2
SCHEMBL13115735 0.89 KDM4E (0.52) KDM4EPTGDR2USP1USP19UCHL3
SCHEMBL2818553 0.89 TP53 (0.49) KDM4EPTGDR2LMNAADCY1SMN1; SMN2
SCHEMBL13115521 0.88 KDM4E (0.51) KDM4EPTGDR2USP1USP19UCHL3
SCHEMBL13115736 0.87 KDM4E (0.50) KDM4EPTGDR2USP1USP19UCHL3
SCHEMBL13115784 0.87 KDM4E (0.50) KDM4EPTGDR2USP1USP19UCHL3
SCHEMBL13115748 0.87 IKBKB (0.46) KDM4ELMNAPPARGPPARATP53
Hydrochloric Acid SCHEMBL2820159 0.86 KDM4E (0.49) KDM4EPTGDR2USP1LMNAPOLB
SCHEMBL13115742 0.86 AVPR1B (0.50) KDM4ENR4A2LMNAPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 KDM4E 801/4885PTGDR2 1487/4885USP1 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.